ClinicalTrials.gov record
Open-Label Extension Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis
ClinicalTrials.gov ID: NCT04286607
Public ClinicalTrials.gov record NCT04286607. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
ClinicalTrials.gov public records Last synced May 18, 2026, 10:25 AM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Open-Label Extension Study of the Long-Term Safety of ARQ-151 Cream 0.3% in Subjects With Chronic Plaque Psoriasis
Study identification
- NCT ID
- NCT04286607
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Arcutis Biotherapeutics, Inc.
- Industry
- Enrollment
- 333 participants
Conditions and interventions
Conditions
Not listed
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 2 Years to 11 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 11, 2020
- Primary completion
- Jan 21, 2024
- Completion
- Jan 21, 2024
- Last update posted
- Jan 6, 2025
2020 – 2024
United States locations
- U.S. sites
- 68
- U.S. states
- 25
- U.S. cities
- 61
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arcutis Biotherapeutics Clinical Site 203 | Scottsdale | Arizona | 85255 | — |
| Arcutis Biotherapeutics Clinical Site 239 | Beverly Hills | California | 90212 | — |
| Arcutis Biotherapeutics Clinical Site 127 | Encinitas | California | 92024 | — |
| Arcutis Biotherapeutics Clinical Site 225 | Encino | California | 91436 | — |
| Arcutis Biotherapeutics Clinical Site 509 | Fountain Valley | California | 92708 | — |
| Arcutis Biotherapeutics Clinical Site 112 | Fremont | California | 94538 | — |
| Arcutis Biotherapeutics Clinical Site 120 | Irvine | California | 92697 | — |
| Arcutis Biotherapeutics Clinical Site 508 | Los Angeles | California | 90057 | — |
| Arcutis Biotherapeutics Clinical Site 511 | Rancho Santa Margarita | California | 92688 | — |
| Arcutis Biotherapeutics Clinical Site 123 | San Diego | California | 92123 | — |
| Arcutis Biotherapeutics Clinical Site 220 | San Diego | California | 92123 | — |
| Arcutis Biotherapeutics Clinical Site 136 | San Francisco | California | 94132 | — |
| Arcutis Biotherapeutics Clinical Site 208 | Santa Monica | California | 90404 | — |
| Arcutis Biotherapeutics Clinical Site 215 | Santa Monica | California | 90503 | — |
| Arcutis Biotherapeutics Clinical Site 223 | Boynton Beach | Florida | 91436 | — |
| Arcutis Biotherapeutics Clinical Site 237 | DeLand | Florida | 32720 | — |
| Arcutis Biotherapeutics Clinical Site 118 | Delray Beach | Florida | 33484 | — |
| Arcutis Biotherapeutics Clinical Site 202 | Hialeah | Florida | 33016 | — |
| Arcutis Biotherapeutics Clinical Site 228 | Largo | Florida | 33770 | — |
| Arcutis Biotherapeutics Clinical Site 131 | Miami | Florida | 33174 | — |
| Arcutis Biotherapeutics Clinical Site 201 | North Miami Beach | Florida | 33162 | — |
| Arcutis Biotherapeutics Clinical Site 137 | Ocala | Florida | 34470 | — |
| Arcutis Biotherapeutics Clinical Site 105 | Sanford | Florida | 32771 | — |
| Arcutis Biotherapeutics Clinical Site 209 | Sweetwater | Florida | 33172 | — |
| Arcutis Clinical Site 602 | Boise | Idaho | 83706 | — |
| Arcutis Biotherapeutics Clinical Site 114 | Plainfield | Illinois | 46168 | — |
| Arcutis Biotherapeutics Clinical Site 102 | Rolling Meadows | Illinois | 60008 | — |
| Arcutis Biotherapeutics Clinical Site 214 | Indianapolis | Indiana | 46250 | — |
| Arcutis Biotherapeutics Clinical Site 217 | Louisville | Kentucky | 40217 | — |
| Arcutis Biotherapeutics Clinical Site 111 | Baton Rouge | Louisiana | 70809 | — |
| Arcutis Biotherapeutics Clinical Site 211 | Lake Charles | Louisiana | 70605 | — |
| Arcutis Biotherapeutics Clinical Site 213 | Metairie | Louisiana | 70006 | — |
| Arcutis Biotherapeutics Clinical Site 224 | New Orleans | Louisiana | 70115 | — |
| Arcutis Biotherapeutics Clinical Site 125 | Rockville | Maryland | 20850 | — |
| Arcutis Biotherapeutics Clinical Site 138 | Rockville | Maryland | 20850 | — |
| Arcutis Biotherapeutics Clinical Site 101 | Brighton | Massachusetts | 02135 | — |
| Arcutis Biotherapeutics Clinical Site 116 | Clinton Township | Michigan | 48038 | — |
| Arcutis Biotherapeutics Clinical Site 212 | Detroit | Michigan | 48202 | — |
| Arcutis Biotherapeutics Clinical Site 216 | Fridley | Minnesota | 55432 | — |
| Arcutis Biotherapeutics Clinical Site 227 | Saint Joseph | Missouri | 64506 | — |
| Arcutis Biotherapeutics Clinical Site 219 | Las Vegas | Nevada | 89148 | — |
| Arcutis Biotherapeutics Clinical Site 231 | Las Vegas | Nevada | 89148 | — |
| Arcutis Biotherapeutics Clinical Site 139 | Reno | Nevada | 89509 | — |
| Arcutis Biotherapeutics Clinical Site 240 | Reno | Nevada | 89703 | — |
| Arcutis Biotherapeutics Clinical Site 236 | Portsmouth | New Hampshire | 03801 | — |
| Arcutis Biotherapeutics Clinical Site 129 | East Windsor | New Jersey | 08520 | — |
| Arcutis Biotherapeutics Clinical Site 121 | New York | New York | 10029 | — |
| Arcutis Biotherapeutics Clinical Site 130 | Rochester | New York | 14623 | — |
| Arcutis Biotherapeutics Clinical Site 108 | Stony Brook | New York | 11790 | — |
| Arcutis Biotherapeutics Clinical Site 115 | High Point | North Carolina | 27262 | — |
| Arcutis Biotherapeutics Clinical Site 124 | Fairborn | Ohio | 45324 | — |
| Arcutis Biotherapeutics Clinical Site 222 | Oklahoma City | Oklahoma | 73112 | — |
| Arcutis Biotherapeutics Clinical Site 134 | Oklahoma City | Oklahoma | 73118 | — |
| Arcutis Biotherapeutics Clinical Site 229 | Broomall | Pennsylvania | 19008 | — |
| Arcutis Biotherapeutics Clinical Site 128 | Duncansville | Pennsylvania | 16635 | — |
| Arcutis Biotherapeutics Clinical Site 113 | Exton | Pennsylvania | 19003 | — |
| Arcutis Biotherapeutics Clinical Site 135 | Pittsburgh | Pennsylvania | 15213 | — |
| Arcutis Biotherapeutics Clinical Site 233 | Knoxville | Tennessee | 37922 | — |
| Arcutis Biotherapeutics Clinical Site 221 | Murfreesboro | Tennessee | 37130 | — |
| Arcutis Biotherapeutics Clinical Site 206 | Arlington | Texas | 76011 | — |
| Arcutis Biotherapeutics Clinical Site 104 | College Station | Texas | 77845 | — |
| Arcutis Biotherapeutics Clinical Site 119 | Dallas | Texas | 75246 | — |
| Arcutis Biotherapeutics Clinical Site 519 | Frisco | Texas | 75034 | — |
| Arcutis Biotherapeutics Clinical Site 238 | Houston | Texas | 77030 | — |
| Arcutis Biotherapeutics Clinical Site 110 | San Antonio | Texas | 78218 | — |
| Arcutis Biotherapeutics Clinical Site 117 | San Antonio | Texas | 78229 | — |
| Arcutis Biotherapeutics Clinical Site 210 | West Jordan | Utah | 84088 | — |
| Arcutis Biotherapeutics Clinical Site 230 | Richmond | Virginia | 23220 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04286607, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 6, 2025 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04286607 live on ClinicalTrials.gov.